app_store_button

google_play_button

SE - Details page - Device banner - 894x1036

Kliv in i en oändlig värld av stories

Lyssna när som helst, var som helst

Daniel Faggella

The AI in Business Podcast is for non-technical business leaders who need to find AI opportunities, align AI capabilities with strategy, and deliver ROI.

Each week, Emerj research staff and journalists interview top AI executives from Fortune 2000 firms and unicorn startups - uncovering trends, use-cases, and best practices for practical AI adoption.

Visit our advertising page to learn more about reaching our executive audience of Fortune 2000 AI adopters: https://emerj.com/advertise

The AI in Business Podcast

Today's guest is Sachit Kamat, Chief Product Officer at Eightfold AI. Eightfold AI provides a complete AI platform for talent management to help companies find, recruit, and retain workers with the goal of increasing the efficiency and effectiveness of talent operations. Sachit joins Emerj Editorial Director Matthew DeMello to discuss how agentic AI enables HR teams to move from human-scale to machine-scale processes, rethinking how organizations identify, assess, and mobilize talent. The conversation also covers how agentic systems can enhance compliance, accelerate change management, and create measurable ROI by automating interview workflows and optimizing internal mobility. This episode is sponsored by Eightfold AI. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Agentic AI and the Strategy Behind Smarter Talent Decisions - with Sachit Kamat of Eightfold AI

Today's guest is Greg Ratcliff, Chief Innovation Officer at Vertiv. With 30 years of experience leading technology teams and global innovation initiatives, Gregory offers deep expertise in data, IoT, and digital infrastructure. Ratcliff joins Emerj Editorial Director Matthew DeMello to discuss how enterprise leaders can scale AI effectively by building the right infrastructure and addressing key bottlenecks. Gregory also shares practical strategies for modular, hybrid data environments, bridging talent gaps, and improving operational efficiency across AI workflows. Join an exclusive circle of AI leaders shaping the conversation in business. Share your AI adoption story and be considered as a future guest on the 'AI in Business' podcast. Apply now at emerj.com/expert2.This episode is sponsored by Pure Storage. See how your brand can partner with Emerj to share insights and reach decision-makers. Get started at emerj.com/ad1.

Scaling GenAI Without Burdening the Data Center - with Greg Ratcliff of Vertiv

Today's guest is Jim Johnson, President at AnswerRocket. Founded in 2013, AnswerRocket builds enterprise AI agents delivering measurable outcomes for Fortune 2000 clients across consumer goods, financial services, construction, real estate, and beyond. Johnson joins Emerj Editorial Director Matthew DeMello to discuss how consumer packaged goods companies can overcome data complexity and accelerate decision-making with emerging agentic AI capabilities. The conversation also examines how CPG teams can shorten analysis cycles, reduce dependence on manual reporting, and uncover new revenue opportunities by pairing existing human expertise with continuously learning AI agents. This episode is sponsored by AnswerRocket. Interested in putting your AI product in front of household names in the Fortune 500? Connect directly with enterprise leaders at market-leading companies. Emerj can position your brand where enterprise decision-makers turn for insight, research, and guidance. Visit emerj.com/sponsor.

CPG Data Challenges to Business Value with Agentic AI - with Jim Johnson of AnswerRocket

Today's guests are Matt Berseth, Co-founder and CIO at NLP Logix, and Russell Dixon, Strategic Advisor at NLP Logix. NLP Logix is a fast-growing AI services firm based in Florida that serves both the public and private sectors. Berseth and Dixon join Emerj Editorial Director Matthew DeMello to discuss how enterprise leaders can successfully deploy AI collaboration tools like ChatGPT Enterprise and Microsoft Copilot, set the right foundations for adoption, and measure ROI. They also share practical takeaways on identifying high-value use cases, tracking meaningful usage and productivity metrics, creating feedback loops to share best practices, and embedding AI tools into workflows to deliver sustained business impact. This episode is sponsored by NLP Logix. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Making Microsoft Copilot and ChatGPT Enterprise Work for You - with Matt Berseth and Russell Dixon of NLP Logix

Today's guest is Emily Nguyen, Head of Industrials and Warp Speed at Palantir Technologies. Emily joins Emerj Editorial Director Matthew DeMello on the show to discuss the realities of AI adoption on the factory floor. Despite rapid advances in AI, many manufacturers still rely on legacy systems, siloed data, and even pen-and-paper processes. Emily shares insights from her 12 years at Palantir on how to bridge these gaps, connect critical functions, and build organizational readiness for AI. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

How Enterprise Industrial Leaders Are Applying AI to Systemic Manufacturing Problems - with Emily Nguyen of Palantir Technologies

Today's guest is Dag Liodden, Chief Product Officer and Co-founder at Crisp. Crisp combines the power of agentic AI with deep retail expertise. Over 7,000 brands leverage Crisp to manage and enrich their retail data to surface valuable insights and drive sales and supply chain performance. Dag joins Emerj Editorial Director Matthew DeMello to discuss why vertical expertise in CPG is essential for unlocking AI's potential, and how creating an AI-ready foundation through data harmonization transforms workflows – from category and promotion management to supply chain optimization. He also explains how this foundation allows teams to focus on strategic work, while AI-powered agents improve real-time performance, reduce human error, and drive measurable ROI across product portfolios. This episode is sponsored by Crisp. Discover how leading brands partner with Emerj to grow their profile and drive impact. Explore partnership opportunities at emerj.com/ad1. Share your insights, grow your profile, and join an elite circle of AI leaders. Apply to be a future' AI in Business' podcast guest at emerj.com/expert2.

Building an AI Ready Data Foundation for CPG Success - with Dag Liodden of Crisp

As agentic AI becomes a defining force in enterprise innovation, infrastructure has moved from a back-office concern to the beating heart of business transformation. On today's episode of the 'AI in Business' podcast, Ranjan Sinha, IBM Fellow, Vice President, and Chief Technology Officer for watsonx and IBM Research, joins Emerj Editorial Director Matthew DeMello to discuss the future of scalable AI infrastructure — from neuromorphic and quantum processing to open-source AI platforms built for trust and governance. Ranjan explains how enterprises are transitioning from isolated experiments to mission-critical AI applications, revealing why today's Fortune 500 leaders must reimagine compute, governance, and data pipelines to sustain automation and reliability at scale. He details IBM's breakthroughs in specialized processors, including the NorthPole neuromorphic chip and the company's roadmap for fault-tolerant quantum computing by 2029. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast! If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show! Watch Matthew and Ranjan's conversation on our new YouTube Channel: youtube.com/@EmerjAIResearch.

Architecting Enterprise AI for Generative and Agentic Systems - with Ranjan Sinha of IBM

Today's guest is Scott Bradley, VP of AI and Innovation at Novartis. As the eighth largest pharmaceutical company in the world by revenue, Novartis' medicines reach millions of people worldwide. Their focus on the discovery and development of novel, breakthrough treatments sees them reimagining not just the delivery of said treatments, but the practice of medicine at large. Scott joins Emerj Editorial Director Matthew DeMello to examine how artificial intelligence is transforming trial design, operations, and patient engagement — while also reshaping industry trust and accountability. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Rethinking Clinical Trial Operations with AI and Remote Monitoring - with Scott Bradley of Novartis

Today's guest is Xiong Liu, Director of Data Science and AI at Novartis. Novartis is among the world's leading pharmaceutical companies, pioneering data and advanced analytics in the pursuit of new medicines and patient outcomes. Xiong joins Emerj Editorial Director Matthew DeMello to examine how generative AI and foundation models are transforming R&D, clinical workflows, and research collaboration across the life sciences. The discussion highlights how domain-specific data strategies, improved data quality, and shared benchmarks are accelerating discovery and operationalizing AI for measurable ROI in biopharma. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast! If you've enjoyed or benefited from some of the insights of this episode, consider leaving us a five-star review on Apple Podcasts, and let us know what you learned, found helpful, or liked most about this show!

Building AI-Ready Cultures in Life Sciences R&D - with Xiong Liu of Novartis

Today's guest is Mathias Cousin, Managing Director at Deloitte. With extensive experience in R&D transformation and regulated industry data strategy, Mathias joins Emerj Editorial Director Matthew DeMello to unpack what it really takes for enterprise leaders to deliver ROI from AI and data initiatives. Mathias also shares actionable guidance on building effective "string of pearls" use cases, investing in data quality and AI-native talent, and adopting practical change management to embed AI in workflows for measurable gains in efficiency and long-term competitive edge. This episode is sponsored by Deloitte. Learn how brands work with Emerj and other Emerj Media options at emerj.com/ad1. Want to share your AI adoption story with executive peers? Click emerj.com/expert2 for more information and to be a potential future guest on the 'AI in Business' podcast!

Rethinking How Life Sciences Organizations Approach AI - Mathias Cousin of Deloitte

This week on AI in Industry, we speak with Amir Saffari, Senior Vice President of AI at BenevolentAI, a London-based pharmaceutical company that uses machine learning to find new uses for existing drugs and new treatments for diseases.
 
In speaking with him, we aim to learn two things:
 
 How will machine learning play a role in the phases of drug discovery, from generating hypotheses to clinical trials? In the future, what are the roles of man and machine in drug discovery? What processes will machines automate and potentially do better than humans in this field? 
We hope the insights in this episode provide business leaders in the pharma industry with an understanding of the current state of AI in their space and where it might play a role in their industry in the next two to three years.
 
See the full interview article here: www.techemergence.com/future-drug-discovery-ai-role-man-machine

The Future of Drug Discovery and AI - The Role of Man and Machine

Lyssna när som helst, var som helst

Andra podcasts som du kanske gillar...